Title: Etoday-- LegoChem's share buyback increases confidence

Publication: Etoday/ Eugene Kim

Date: 21 October 2015

Summary

• Through the share buyback, CEO and the management of LegoChem has increased confidence in their growth in business.

• CFO Se Jin Park said, "We bought back our share to emphasize responsibility management and to improve our stock value. This is to express that we're confident in our growth and we will be active in tranferring technology and improving sales performance.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).